{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:22:45Z","timestamp":1791235365723,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,6,15]],"date-time":"2010-06-15T00:00:00Z","timestamp":1276560000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1007\/s00428-010-0939-z","type":"journal-article","created":{"date-parts":[[2010,6,14]],"date-time":"2010-06-14T09:07:20Z","timestamp":1276506440000},"page":"27-34","source":"Crossref","is-referenced-by-count":53,"title":["Does high-grade endometrioid carcinoma (grade 3 FIGO) belong to type I or type II endometrial cancer? A clinical\u2013pathological and immunohistochemical study"],"prefix":"10.1007","volume":"457","author":[{"given":"Gian Franco","family":"Zannoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio Gaetano","family":"Vellone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Arena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Prisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Scambia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaldo","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,6,15]]},"reference":[{"key":"939_CR1","volume-title":"World cancer report","year":"2003","unstructured":"Stewart BW, Kleihues P (eds) (2003) World cancer report. IARC, Lyon"},{"key":"939_CR2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00428-003-0947-3","volume":"444","author":"SF Lax","year":"2004","unstructured":"Lax SF (2004) Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification. Virchows Arch 444:213\u2013223, Review","journal-title":"Virchows Arch"},{"key":"939_CR3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","volume":"15","author":"JV Bokhman","year":"1983","unstructured":"Bokhman JV (1983) Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15:10\u201317","journal-title":"Gynecol Oncol"},{"key":"939_CR4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/107327480901600102","volume":"16","author":"N Bansal","year":"2009","unstructured":"Bansal N, Yendluri V, Wenham RM (2009) The molecular biology of endometrial cancers and the implications for pathogenesis, classification, and targeted therapies. Cancer Control 16:8\u201313, Review","journal-title":"Cancer Control"},{"key":"939_CR5","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1046\/j.1365-2559.1998.00560.x","volume":"33","author":"JL Burton","year":"1998","unstructured":"Burton JL, Wells M (1998) Recent advances in the histopathology and molecular pathology of carcinoma of the endometrium. Histopathology 33:297\u2013303, Review","journal-title":"Histopathology"},{"key":"939_CR6","doi-asserted-by":"crossref","first-page":"6422","DOI":"10.1158\/1078-0432.CCR-05-0508","volume":"11","author":"KK Zorn","year":"2005","unstructured":"Zorn KK, Bonome T, Gangi L et al (2005) Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer. Clin Cancer Res 11:6422\u20136430","journal-title":"Clin Cancer Res"},{"key":"939_CR7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4065\/83.1.97","volume":"83","author":"JN Bakkum-Gamez","year":"2008","unstructured":"Bakkum-Gamez JN, Gonzalez-Bosquet J, Laack NN et al (2008) Current issues in the management of endometrial cancer. Mayo Clin Proc 83:97\u2013112, Review","journal-title":"Mayo Clin Proc"},{"key":"939_CR8","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(05)67063-8","volume":"366","author":"F Amant","year":"2005","unstructured":"Amant F, Moerman P, Neven P et al (2005) Endometrial cancer. Lancet 366:491\u2013505, Review","journal-title":"Lancet"},{"key":"939_CR9","first-page":"125","volume":"35","author":"International Federation of Gynecology and Obstetrics (FIGO)","year":"1999","unstructured":"International Federation of Gynecology and Obstetrics (FIGO) (1999) Announcements. FIGO stages: 1998 revision. Gynecol Oncol 35:125\u2013127","journal-title":"Gynecol Oncol"},{"key":"939_CR10","first-page":"235","volume-title":"Gynecologic pathology","author":"X Matias-Guiu","year":"2009","unstructured":"Matias-Guiu X (2009) Endometrial neoplasia. In: Nucci MR, Oliva E (eds) Gynecologic pathology. Churchill and Livingstone, London, pp 235\u2013259"},{"key":"939_CR11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00004347-200404000-00007","volume":"23","author":"A Alkushi","year":"2004","unstructured":"Alkushi A, Lim P, Coldman A, Huntsman D, Miller D, Gilks CB (2004) Interpretation of p53 immunoreactivity in endometrial carcinoma: establishing a clinically relevant cut-off level. Int J Gynecol Pathol 23:129\u2013137","journal-title":"Int J Gynecol Pathol"},{"key":"939_CR12","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s10585-007-9087-5","volume":"24","author":"R Jeczen","year":"2007","unstructured":"Jeczen R, Skomra D, Cybulski M, Schneider-Stock R, Szewczuk W, Roessner A, Rechberger T, Semczuk A (2007) P53\/MDM2 overexpression in metastatic endometrial cancer: correlation with clinicopathological features and patient outcome. Clin Exp Metastasis 24:503\u2013511","journal-title":"Clin Exp Metastasis"},{"key":"939_CR13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/107327480901600107","volume":"16","author":"A Mendivil","year":"2009","unstructured":"Mendivil A, Schuler KM, Gehrig PA (2009) Non-endometrioid adenocarcinoma of the uterine corpus: a review of selected histological subtypes. Cancer Control 16:46\u201352","journal-title":"Cancer Control"},{"key":"939_CR14","first-page":"501","volume-title":"Blaustein\u2019s pathology of the female genital tract","author":"BM Ronnet","year":"2002","unstructured":"Ronnet BM, Zaino RJ, Ellenson LH et al (2002) Endometrial carcinoma. In: Kurman RJ (ed) Blaustein\u2019s pathology of the female genital tract. Springer, New York, pp 501\u2013559"},{"key":"939_CR15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jsbmb.2007.09.020","volume":"108","author":"A Doll","year":"2008","unstructured":"Doll A, Abal M, Rigau M et al (2008) Novel molecular profiles of endometrial cancer-new light through old windows. J Steroid Biochem Mol Biol 108:221\u2013229","journal-title":"J Steroid Biochem Mol Biol"},{"key":"939_CR16","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/0046-8177(95)90204-X","volume":"26","author":"ME Sherman","year":"1995","unstructured":"Sherman ME, Bur ME, Kurman RJ (1995) p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis. Hum Pathol 26:1268\u20131274","journal-title":"Hum Pathol"},{"key":"939_CR17","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJM199608293350907","volume":"335","author":"PG Rose","year":"1996","unstructured":"Rose PG (1996) Endometrial carcinoma. N Engl J Med 335:640\u2013649","journal-title":"N Engl J Med"},{"key":"939_CR18","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1200\/JCO.1999.17.5.1382","volume":"17","author":"HB Salvesen","year":"1999","unstructured":"Salvesen HB, Iversen OE, Akslen LA (1999) Prognostic significance of angiogenesis and Ki-67, p53, and p21 expression: a population-based endometrial carcinoma study. J Clin Oncol 17:1382\u20131390","journal-title":"J Clin Oncol"},{"key":"939_CR19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1586\/14737140.6.1.33","volume":"6","author":"J Carter","year":"2006","unstructured":"Carter J, Pather S (2006) An overview of uterine cancer and its management. Expert Rev Anticancer Ther 6:33\u201342, Review","journal-title":"Expert Rev Anticancer Ther"},{"key":"939_CR20","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0046-8177(98)90197-6","volume":"29","author":"SF Lax","year":"1998","unstructured":"Lax SF, Pizer ES, Ronnett BM, Kurman RJ (1998) Comparison of estrogen and progesterone receptor, Ki-67, and p53 immunoreactivity in uterine endometrioid carcinoma and endometrioid carcinoma with squamous, mucinous, secretory, and ciliated cell differentiation. Hum Pathol 29:924\u2013931","journal-title":"Hum Pathol"},{"key":"939_CR21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ygyno.2003.12.038","volume":"93","author":"S Oreskovic","year":"2004","unstructured":"Oreskovic S, Babic D, Kalafatic D et al (2004) A significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinoma. Gynecol Oncol 93:34\u201340","journal-title":"Gynecol Oncol"},{"key":"939_CR22","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1517\/14656560903061291","volume":"10","author":"NI Barrena Medel","year":"2009","unstructured":"Barrena Medel NI, Bansal S, Miller DS et al (2009) Pharmacotherapy of endometrial cancer. Expert Opin Pharmacother 10:1939\u20131951, Review","journal-title":"Expert Opin Pharmacother"},{"key":"939_CR23","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1677\/ERC-08-0266","volume":"16","author":"P Chaudhry","year":"2009","unstructured":"Chaudhry P, Asselin E (2009) Resistance to chemotherapy and hormone therapy in endometrial cancer. Endocr Relat Cancer 16:363\u2013380","journal-title":"Endocr Relat Cancer"},{"key":"939_CR24","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1136\/jcp.2009.071225","volume":"63","author":"BA Clarke","year":"2010","unstructured":"Clarke BA, Gilks CB (2010) Endometrial carcinoma: controversies in histopathological assessment of grade and tumour cell type. J Clin Pathol 63:410\u2013415","journal-title":"J Clin Pathol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-010-0939-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-010-0939-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-010-0939-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T17:35:57Z","timestamp":1559064957000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-010-0939-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,15]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["939"],"URL":"https:\/\/doi.org\/10.1007\/s00428-010-0939-z","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,15]]}}}